4//SEC Filing
OSBORNE DAVID W 4
Accession 0001567619-21-005542
CIK 0001787306other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:50 PM ET
Size
5.1 KB
Accession
0001567619-21-005542
Insider Transaction Report
Form 4
OSBORNE DAVID W
Chief Technical Officer
Transactions
- Sale
Common Stock
2021-03-01$34.57/sh−780$26,968→ 237,253 total
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). Shares and RSUs remain subject to a lock-up agreement with the underwriters for the Issuer's follow-on offering in February 2021.
- [F2]Includes 6,750 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001252999
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:50 PM ET
- Size
- 5.1 KB